367 related articles for article (PubMed ID: 19437191)
41. Inguinal metastasis of a bladder mixed carcinoma with predominant adenocarcinoma component.
Hamano A; Udagawa K; Nomura S; Ishida T
Scand J Urol Nephrol; 2006; 40(1):75-7. PubMed ID: 16452061
[TBL] [Abstract][Full Text] [Related]
42. Lymph node dissection in bladder cancer: Where do we stand?
Hugen CM; Daneshmand S
World J Urol; 2017 Apr; 35(4):527-533. PubMed ID: 26712616
[TBL] [Abstract][Full Text] [Related]
43. Accuracy of the extent of bladder cancer nodal metastases found at pelvic lymphadenectomy at the time of cystectomy: relation to primary tumor stage.
Rabbani F; Lee C; Chang SS; Lerner SP; Wood DP; Herr HW
Urol Int; 2010; 84(1):14-22. PubMed ID: 20173363
[TBL] [Abstract][Full Text] [Related]
44. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
45. Re: patterns of initial transitional cell recurrence in patients after cystectomy.
Zaghloul MS
J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607
[No Abstract] [Full Text] [Related]
46. Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens.
Gordetsky J; Scosyrev E; Rashid H; Wu G; Silvers C; Golijanin D; Messing EM; Yao JL
Mod Pathol; 2012 Jan; 25(1):140-4. PubMed ID: 21909079
[TBL] [Abstract][Full Text] [Related]
47. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
[TBL] [Abstract][Full Text] [Related]
48. Molecular lymph node staging in bladder urothelial carcinoma: impact on survival.
Marín-Aguilera M; Mengual L; Burset M; Oliver A; Ars E; Ribal MJ; Colomer D; Mellado B; Villavicencio H; Algaba F; Alcaraz A
Eur Urol; 2008 Dec; 54(6):1363-72. PubMed ID: 18486306
[TBL] [Abstract][Full Text] [Related]
49. Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study.
Adsan O; Baltaci S; Cal C; Büyükalpelli R; Uğurlu O; Bozlu M; Türkölmez K; Sahin H; Elhan A
Urology; 2007 Jan; 69(1):83-6. PubMed ID: 17270622
[TBL] [Abstract][Full Text] [Related]
50. Innovations in radical cystectomy and pelvic lymph node dissection.
Stamatakis L; Godoy G; Lerner SP
Semin Oncol; 2012 Oct; 39(5):573-82. PubMed ID: 23040253
[TBL] [Abstract][Full Text] [Related]
51. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis.
Leissner J; Hohenfellner R; Thüroff JW; Wolf HK
BJU Int; 2000 May; 85(7):817-23. PubMed ID: 10792159
[TBL] [Abstract][Full Text] [Related]
52. Hospital lymph node counts and survival after radical cystectomy.
Hollenbeck BK; Ye Z; Wong SL; Montie JE; Birkmeyer JD
Cancer; 2008 Feb; 112(4):806-12. PubMed ID: 18085612
[TBL] [Abstract][Full Text] [Related]
53. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
[TBL] [Abstract][Full Text] [Related]
54. Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer.
Nagele U; Anastasiadis AG; Merseburger AS; Sievert KD; Stenzl A; Kuczyk M
Expert Rev Anticancer Ther; 2006 Jun; 6(6):871-6. PubMed ID: 16761930
[TBL] [Abstract][Full Text] [Related]
55. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
[TBL] [Abstract][Full Text] [Related]
56. [Imaging procedures in preoperative lymph node staging of invasive bladder cancer. Necessary or superfluous?].
Gottfried HW; Miller K; Brandes H; Henze E; Waidelich HA
Urologe A; 1993 Jan; 32(1):56-8. PubMed ID: 8447046
[TBL] [Abstract][Full Text] [Related]
57. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
[TBL] [Abstract][Full Text] [Related]
58. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
Necchi A; Mariani L; Lo Vullo S; Yu EY; Woods ME; Wong YN; Harshman LC; Alva A; Sternberg CN; Bamias A; Grivas P; Koshkin VS; Roghmann F; Dobruch J; Eigl BJ; Nappi L; Milowsky MI; Niegisch G; Pal SK; De Giorgi U; Recine F; Vaishampayan U; Berthold DD; Bowles DW; Baniel J; Theodore C; Ladoire S; Srinivas S; Agarwal N; Crabb S; Sridhar S; Golshayan AR; Ohlmann C; Xylinas E; Powles T; Rosenberg JE; Bellmunt J; van Rhijn B; Galsky MD; Hendricksen K;
Eur Urol Focus; 2019 Mar; 5(2):242-249. PubMed ID: 28753897
[TBL] [Abstract][Full Text] [Related]
59. Radical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian cohort.
Corradi RB; Galvao GJ; Oliveira GM; Carneiro VF; Miconi WG; Salles PG; Cabral WL; Corradi C; Salazar AL
Int Braz J Urol; 2016; 42(3):431-7. PubMed ID: 27286104
[TBL] [Abstract][Full Text] [Related]
60. [Cystectomy in the treatment of bladder cancer].
Babjuk M; Hanus T; Safarík L; Dvorácek J; Pavlík I; Soukup V; Pesl M; Szakacsová M; Dusková J
Cas Lek Cesk; 2007; 146(10):751-7. PubMed ID: 18020006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
